The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

被引:0
作者
C. J. Currie
C. D. Poole
E. A. M. Gale
机构
[1] Cardiff University,School of Medicine
[2] The Pharma Research Centre,Department of Epidemiology
[3] Cardiff MediCentre,Diabetes and Metabolism, School of Medicine
[4] Pharmatelligence,undefined
[5] Bristol University,undefined
来源
Diabetologia | 2009年 / 52卷
关键词
Cancer; Insulin; Insulin analogues; Metformin; Sulfonylureas; Survival; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1766 / 1777
页数:11
相关论文
共 83 条
[71]  
Khaw K-T(undefined)undefined undefined undefined undefined-undefined
[72]  
Wareham N(undefined)undefined undefined undefined undefined-undefined
[73]  
Bingham S(undefined)undefined undefined undefined undefined-undefined
[74]  
Luben R(undefined)undefined undefined undefined undefined-undefined
[75]  
Welch A(undefined)undefined undefined undefined undefined-undefined
[76]  
Holman RR(undefined)undefined undefined undefined undefined-undefined
[77]  
Paul SK(undefined)undefined undefined undefined undefined-undefined
[78]  
Bethel A(undefined)undefined undefined undefined undefined-undefined
[79]  
Matthews DR(undefined)undefined undefined undefined undefined-undefined
[80]  
Neil AW(undefined)undefined undefined undefined undefined-undefined